{"id":"W2010150087","doi":"10.1177/1076029610389028","title":"The United States Food and Drugs Administration Approves a Generic Enoxaparin","year":2010,"lang":"en","type":"article","venue":"Clinical and Applied Thrombosis/Hemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Biosimilar; Food and drug administration; Mandate; Medicine; Agency (philosophy); Orphan drug; Interchangeability; Drug approval; Pharmacology; Business; Generic drug; Drug; Engineering; Political science; Bioinformatics; Law; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007079433,0.0002678423,0.0006016737,0.00006306871,0.0004603226,0.0001625408,0.0001362876,0.0001938141,0.0000406745],"category_scores_gemma":[0.0001150806,0.0001778381,0.0001030512,0.0002513421,0.0007651623,0.00004947103,0.0001928826,0.0004780526,0.00001662064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008549266,"about_ca_system_score_gemma":0.00005504841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000341059,"about_ca_topic_score_gemma":0.00008105397,"domain_scores_codex":[0.9981509,0.00004766006,0.0006295862,0.000549511,0.0002491038,0.0003731889],"domain_scores_gemma":[0.998406,0.0005689686,0.0001732088,0.0004542563,0.00006649375,0.0003310926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0006578375,0.004051689,0.01823561,0.000439449,0.001876554,0.000008463198,0.002117476,0.000004280001,0.0061466,0.1459071,0.02934754,0.7912074],"study_design_scores_gemma":[0.007099961,0.003706507,0.5616023,0.0001202235,0.001833306,0.00002931514,0.007083568,0.0009667782,0.0158075,0.01650907,0.3840897,0.001151721],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883673,0.0002045553,0.0000655479,0.007383693,0.0002393541,0.00077959,0.00001845404,0.00009196793,0.002849551],"genre_scores_gemma":[0.9900104,0.005068802,0.001259346,0.00304119,0.0002609276,0.0001381641,0.0001019249,0.00003346599,0.00008580869],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7900556,"threshold_uncertainty_score":0.7252029,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04218167370557662,"score_gpt":0.3276312106345329,"score_spread":0.2854495369289562,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}